Filing status
- Accounts due
- 31 October 2027
- Last accounts
- 31 January 2026
- Conf. stmt due
- 1 February 2027
- Last conf. stmt
- 18 January 2026
Canivax Limited
- Incorporated
- 19 January 2024 (2 years)
- Previously known as
- Riox Therapeutics Limited (until 19 June 2025)This list may be incomplete. See all names on Companies House
- Industry
- Research and experimental development on biotechnology (72110)
- Owned by
- Nicholas Barrie La Thangue
- Accounts type
- Micro entity
- Region
- South East
- Address
- Magdalen Centre Oxford Science ParkRobert Robinson AvenueOxfordOX4 4GA
Officers
This list may be incomplete. See all officers on Companies House
Officer details are public data from the Companies House register.
Director · Appointed 9 September 2026
British
Born October 1966 (60)
Ownership 1 active
People and entities with significant control, from the Companies House PSC register
Nicholas Barrie La Thangue
Individual · Notified 19 January 2024
Owns 25–50% of shares
Holds 25–50% of voting rights
British
Born November 1957
Former controllers (2)
7 January 2026
Ceased Shunsheng Zheng — Owns 25–50% of shares
7 January 2026
Ceased Collette Coll — Owns 25–50% of shares
Financials
Balance sheet as at 31 January 2026 · micro entity accounts
- Net Assets
- £198,395
- Current Ratio
- 13200.6x
Trend
Net Assets
Balance sheet detail
| 2026 | 2025 | |
|---|---|---|
| Current Assets | £198,009 | |
| Creditors (< 1 year) | £15 | |
| Net Current Assets | £197,994 | |
| Net Assets | £198,395 | £1 |
| Shareholder Funds | £198,395 | £1 |
Filings
Recent filings only. See the full history on Companies House
| Date | Description | Made Up To | Pages | |
|---|---|---|---|---|
| 6 November 2026 | Appointment of a director |
Other companies in this industry
By trade and location
Need accounts figures, ownership or websites for thousands of companies? Bulk data & API →